PDS Biotechnology
NASDAQ: PDSBNorth Brunswick, US · Delaware corporation · 1 known investors
NASDAQ-listed company harnessing immunology for therapeutic development
Biotech
Founders & leadership
FK
Frank K. Bedu-AddoExecutive Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$1.1MraisedSep 2016 · 14 investors · BiotechnologyRule 506(b)
▶$1.1MraisedSep 2016 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank K. Bedu-AddoExecutive Officer
- Offering amount
- $10M
- Amount sold
- $1.1M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$902.5KraisedAug 2016 · 12 investors · BiotechnologyRule 506(b)
▶$902.5KraisedAug 2016 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank K. Bedu-AddoExecutive Officer
- Offering amount
- $1M
- Amount sold
- $902.5K
- Minimum investment
- $10K
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.